Table 1.
Baseline characteristics of study subjects stratified by TG and WC values.
| TG ≥1.7 mmol/l |
WC ≥90 cm(men) or ≥85 cm(women) |
||||||
|---|---|---|---|---|---|---|---|
| ALL (n = 666) |
No (n = 432) |
Yes (n = 234) |
p | No (n = 276) |
Yes (n = 390) |
p | |
| Male sex (%) | 279 (41.89%) | 202 (46.76%) | 77 (32.91%) | .001 | 126 (45.65%) | 153 (39.23%) | .098 |
| Age (year) | 65.58 ± 5.40 | 66.42 ± 5.62 | 64.03 ± 4.61 | <.001 | 66.26 ± 5.61 | 65.10 ± 5.21 | .006 |
| SBP (mmHg) | 133.64 ± 18.85 | 132.09 ± 18.70 | 136.50 ± 18.83 | .004 | 130.07 ± 16.69 | 136.17 ± 19.87 | <.001 |
| DBP (mmHg) | 85.06 ± 9.23 | 84.48 ± 8.92 | 86.14 ± 9.71 | .026 | 83.55 ± 8.55 | 86.13 ± 9.56 | <.001 |
| TC (mmol/l) | 5.17 ± 2.18 | 5.03 ± 2.55 | 5.40 ± 1.20 | .023 | 5.22 ± 3.18 | 5.14 ± 1.98 | .616 |
| TG (mmol/l) | 1.69 ± 1.10 | 1.10 ± 0.32 | 2.79 ± 1.19 | <.001 | 1.31 ± 0.67 | 1.96 ± 1.26 | <.001 |
| BMI (kg/m²) | 25.06 ± 3.48 | 24.34 ± 3.49 | 26.39 ± 3.05 | <.001 | 22.73 ± 2.88 | 26.71 ± 2.86 | <.001 |
| WC (cm) | 88.65 ± 9.36 | 86.63 ± 9.37 | 92.02 ± 8.36 | <.001 | 80.04 ± 5.80 | 94.74 ± 6.01 | <.001 |
| FBG (mmol/l) | 5.18 ± 1.46 | 5.10 ± 1.42 | 5.33 ± 1.53 | .053 | 5.07 ± 1.42 | 5.26 ± 1.49 | .089 |
| Scr (mmol/l) | 71.97 ± 10.45 | 71.79 ± 10.13 | 72.31 ± 11.03 | .541 | 71.22 ± 10.02 | 72.51 ± 10.72 | .116 |
| Urea nitrogen (mmol/l) | 6.02 ± 2.13 | 6.04 ± 1.56 | 5.98 ± 2.92 | .742 | 5.96 ± 1.59 | 6.06 ± 2.45 | .569 |
| Smoking (%) | 287 (43.09%) | 180 (41.67%) | 107 (45.73%) | .312 | 138 (50%) | 149 (38.21%) | .002 |
| Hypertension (%) | 344 (51.65%) | 197 (45.60%) | 147 (62.82%) | <.001 | 116 (42.03%) | 228 (58.46%) | <.001 |
| Diabetes (%) | 69 (10.36%) | 37 (8.56%) | 32 (13.68%) | .039 | 22 (7.97%) | 47 (12.05%) | .089 |
| Drinking (%) | 132 (19.82%) | 100 (23.15%) | 32 (13.68%) | .003 | 57 (20.65%) | 75 (19.23%) | .65 |
| Lipid-lowering treatment (%) | 173 (25.98%) | 14 (3.24%) | 159 (67.95%) | <.001 | 21 (7.61%) | 152 (38.97%) | <.001 |
| Blood-pressure-lowering treatment (%) |
345 (51.80%) | 194 (44.91%) | 144 (61.54%) | <.001 | 111 (40.22%) | 227 (58.21%) | <.001 |
| Antidiabetic treatment (%) | 71 (10.66%) | 34 (7.87%) | 32 (13.68%) | .017 | 21 (7.61%) | 45 (11.54%) | .095 |
| eGFR (ml/min/1.73 m²) | 83.79 ± 10.46 | 84.26 ± 10.33 | 82.93 ± 10.65 | .115 | 84.70 ± 10.46 | 83.16 ± 10.42 | .061 |
Data are mean ± SD or absolute frequency (percentage).
eGFR: estimated glomerular filtration rate; ACR: albumin-to-creatinine ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; TG: triglyceride; TC: total cholesterol; FBG: fasting blood-glucose; WC: waist circumference; Scr: serum creatinine.